The Market Access Special Forces

As partners of our internationally operating clients, we support the successful market access especially of treatments for rare diseases, of ATMPs or of products which set new therapy standards, both on a strategic and operational level. We dedicate our enthusiasm to solving complex problems.
Whitepaper: Routine practice data collection for benefit assessment

Lessons learned from 2 years - risk factors and strategic implications
Successful market access for gene therapies

Strategic challenges and possible solutions - Our exclusive white paper provides a comprehensive analysis to derive key considerations for the strategic challenges for gene therapies in Germany, with a focus on pricing and reimbursement
Digital Health Applications (DiGAs) - the path to reimbursement

With our longstanding AMNOG-expertise we support DiGA-providers with a customized market access strategy – all the way from the development of the value story to successful price negotiations.
Creating value in health care

"A unique combination of deep understanding of the matter, strategic vision, didactic skill and humor."

Founder and CEO of medical-technology company

to the top